Search
Now showing items 11-16 of 16
Artificial Intelligence in Urological Oncology: An update and future applications
(2021-05-20)
There continues to be rapid developments and research in the field of Artificial Intelligence (AI) in Urological Oncology worldwide. In this review we discuss the basics of AI, application of AI per tumour group (Renal, ...
Radical Cystectomy in England from 2013-2019: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data
(2021-03-12)
Introduction We evaluate the data of 12,644 Radical Cystectomies in England (Open, Robotic and Laparoscopic) with trends in the adaption of techniques and post‐operative complications. Methods This analysis utilised national ...
Radical Cystectomy in England from 2013 to 2019 on 12,644 patients: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data
(2021-03-12)
Abstract: Introduction: We evaluate the data of 12,644 Radical Cystectomies in England (Open, Robotic and Laparoscopic) with trends in the adaption of techniques and post‐operative complications. Methods: This analysis ...
Major urological cancer surgery for patients is safe and surgical training should be encouraged during the COVID-19 pandemic : A multi-centre analysis of 30-day outcomes
(2021-03)
COVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with a high risk of progression. We report outcomes for major GU cancer operations, namely radical ...
Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma
(2021-02-01)
Historically, immediate cytoreductive nephrectomy (CN) was considered the standard of care in patients with metastatic renal cell carcinoma (mRCC) who were fit enough to undergo surgery. Recently, 2 randomized controlled ...
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions
(2021-01-01)
This narrative review aims to describe established and emerging urinary biomarkers in the diagnosis and surveillance of non-muscle invasive bladder cancer (NMIBC). It provides a comprehensive account of classical, FDA-approved ...